Can Sustained Product Demand Drive HIMS Stock Before Q3 Earnings?Zacks Investment Research • 10/29/25
HIMS vs. LFMD: Which Telehealth Stock Is the Better Investment Now?Zacks Investment Research • 10/27/25
Hims & Hers Health, Inc. (HIMS) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 10/27/25
HIMS Stock Declines Despite Launch of New Specialty in Women's HealthZacks Investment Research • 10/21/25
Hims & Hers: Q3 Could Provide Volatility, But The Long-Term Vision Remains BrightSeeking Alpha • 10/21/25
S&P 500, Nasdaq Slide On Bad Loan Fears; Broadcom, Hims, Oracle Are Top Stocks To WatchInvestors Business Daily • 10/16/25
Weight-loss drugs shook up the stock market. Menopause treatments could be next.Market Watch • 10/15/25
Hers Launches Menopause and Perimenopause Specialty, Taking the Next Step Toward $1B of Hers Revenue in 2026Business Wire • 10/15/25